Drug Shortage Report for JAMP NEVIRAPINE

Last updated on 2022-09-06 History
Report ID 162493
Drug Identification Number 02405776
Brand name JAMP NEVIRAPINE
Common or Proper name Nevirapine Tablets
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) NEVIRAPINE
Strength(s) 200MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 60
ATC code J05AG
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-31
Estimated end date 2022-11-30
Actual end date 2022-09-02
Shortage status Resolved
Updated date 2022-09-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-09-06 French Compare
v7 2022-09-06 English Compare
v6 2022-08-30 French Compare
v5 2022-08-30 English Compare
v4 2022-08-02 French Compare
v3 2022-08-02 English Compare
v2 2022-06-13 French Compare
v1 2022-06-13 English Compare

Showing 1 to 8 of 8